SRX7783357 Hela_64_XR_NA_async_12_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200026 Hela_64_XR_NA_async_12_A Hela_64_XR_NA_async_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783358 Hela_64_XR_NA_async_12_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200027 Hela_64_XR_NA_async_12_B Hela_64_XR_NA_async_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783359 Hela_CPD_XR_NA_late_12_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200028 Hela_CPD_XR_NA_late_12_A Hela_CPD_XR_NA_late_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783360 Hela_CPD_XR_NA_late_12_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200029 Hela_CPD_XR_NA_late_12_B Hela_CPD_XR_NA_late_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783361 Hela_64_DS_NA_async_12_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200030 Hela_64_DS_NA_async_12_A Hela_64_DS_NA_async_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783362 Hela_64_DS_NA_async_12_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200031 Hela_64_DS_NA_async_12_B Hela_64_DS_NA_async_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783363 Hela_64_DS_NA_early_12_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200032 Hela_64_DS_NA_early_12_A Hela_64_DS_NA_early_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783364 Hela_64_DS_NA_early_12_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200033 Hela_64_DS_NA_early_12_B Hela_64_DS_NA_early_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783365 Hela_64_DS_NA_late_12_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200034 Hela_64_DS_NA_late_12_A Hela_64_DS_NA_late_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783366 Hela_64_DS_NA_late_12_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200035 Hela_64_DS_NA_late_12_B Hela_64_DS_NA_late_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783367 Hela_CPD_DS_NA_async_12_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200036 Hela_CPD_DS_NA_async_12_A Hela_CPD_DS_NA_async_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783368 Hela_CPD_DS_NA_async_12_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200037 Hela_CPD_DS_NA_async_12_B Hela_CPD_DS_NA_async_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783369 Hela_64_XR_NA_early_12_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200038 Hela_64_XR_NA_early_12_A Hela_64_XR_NA_early_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783370 Hela_CPD_DS_NA_early_12_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200039 Hela_CPD_DS_NA_early_12_A Hela_CPD_DS_NA_early_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783371 Hela_CPD_DS_NA_early_12_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200040 Hela_CPD_DS_NA_early_12_B Hela_CPD_DS_NA_early_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783372 Hela_CPD_DS_NA_late_12_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200041 Hela_CPD_DS_NA_late_12_A Hela_CPD_DS_NA_late_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783373 Hela_CPD_DS_NA_late_12_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200042 Hela_CPD_DS_NA_late_12_B Hela_CPD_DS_NA_late_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783374 Hela_CPD_XR_NA_early_120_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200043 Hela_CPD_XR_NA_early_120_A Hela_CPD_XR_NA_early_120_A OTHER GENOMIC other HiSeq X Ten SRX7783375 Hela_CPD_XR_NA_late_120_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200044 Hela_CPD_XR_NA_late_120_A Hela_CPD_XR_NA_late_120_A OTHER GENOMIC other HiSeq X Ten SRX7783376 Hela_CPD_XR_NA_early_120_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200045 Hela_CPD_XR_NA_early_120_B Hela_CPD_XR_NA_early_120_B OTHER GENOMIC other HiSeq X Ten SRX7783377 Hela_CPD_XR_NA_late_120_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200046 Hela_CPD_XR_NA_late_120_B Hela_CPD_XR_NA_late_120_B OTHER GENOMIC other HiSeq X Ten SRX7783378 Hela_CPD_DS_NA_early_120_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200047 Hela_CPD_DS_NA_early_120_A Hela_CPD_DS_NA_early_120_A OTHER GENOMIC other HiSeq X Ten SRX7783379 Hela_CPD_DS_NA_late_120_A SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200048 Hela_CPD_DS_NA_late_120_A Hela_CPD_DS_NA_late_120_A OTHER GENOMIC other HiSeq X Ten SRX7783380 Hela_64_XR_NA_early_12_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200049 Hela_64_XR_NA_early_12_B Hela_64_XR_NA_early_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783381 Hela_CPD_DS_NA_early_120_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200050 Hela_CPD_DS_NA_early_120_B Hela_CPD_DS_NA_early_120_B OTHER GENOMIC other HiSeq X Ten SRX7783382 Hela_CPD_DS_NA_late_120_B SRP250379 bp0 Genomic DNA were fragmented by sonication, followed by end-repair, dA-tailing and adaptor ligation by NEBNext UltraII DNA library preparation kit. Adaptor-ligated fragments were danatured and subjected to IP with damage specific antibodies. Primer extension was performed to detect the exact position of damage on these purified fragments, because DNA polymerase stalls when encountering a lesion. Read-through products were removed by subtractive hybridization, then the rest blocked products were attached to the second adaptor. The ligation products were PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200051 Hela_CPD_DS_NA_late_120_B Hela_CPD_DS_NA_late_120_B OTHER GENOMIC other HiSeq X Ten SRX7783383 Hela_NA_DNAseq_NA_async_NA_NA SRP250379 bp0 Genomic DNA were fragmented by sonication, and the libraries were generated by NEBNext UltraII DNA library preparation kit according to the manufactor's instruction. Resulting libraries were sequenced by Illumina Hiseq system. SRS6200052 Hela_NA_DNAseq_NA_async_NA_NA Hela_NA_DNAseq_NA_async_NA_NA OTHER GENOMIC other HiSeq X Ten SRX7783384 Hela_NA_DNAseq_NA_early_NA_NA SRP250379 bp0 Genomic DNA were fragmented by sonication, and the libraries were generated by NEBNext UltraII DNA library preparation kit according to the manufactor's instruction. Resulting libraries were sequenced by Illumina Hiseq system. SRS6200053 Hela_NA_DNAseq_NA_early_NA_NA Hela_NA_DNAseq_NA_early_NA_NA OTHER GENOMIC other HiSeq X Ten SRX7783385 Hela_NA_DNAseq_NA_late_NA_NA SRP250379 bp0 Genomic DNA were fragmented by sonication, and the libraries were generated by NEBNext UltraII DNA library preparation kit according to the manufactor's instruction. Resulting libraries were sequenced by Illumina Hiseq system. SRS6200054 Hela_NA_DNAseq_NA_late_NA_NA Hela_NA_DNAseq_NA_late_NA_NA OTHER GENOMIC other HiSeq X Ten SRX7783386 Hela_64_XR_NA_late_12_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200055 Hela_64_XR_NA_late_12_A Hela_64_XR_NA_late_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783387 Hela_64_XR_NA_late_12_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200057 Hela_64_XR_NA_late_12_B Hela_64_XR_NA_late_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783388 Hela_CPD_XR_NA_async_12_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200056 Hela_CPD_XR_NA_async_12_A Hela_CPD_XR_NA_async_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783389 Hela_CPD_XR_NA_async_12_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200058 Hela_CPD_XR_NA_async_12_B Hela_CPD_XR_NA_async_12_B OTHER GENOMIC other Illumina HiSeq 2500 SRX7783390 Hela_CPD_XR_NA_early_12_A SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200059 Hela_CPD_XR_NA_early_12_A Hela_CPD_XR_NA_early_12_A OTHER GENOMIC other Illumina HiSeq 2500 SRX7783391 Hela_CPD_XR_NA_early_12_B SRP250379 bp0 Excision products were extracted by co-IP with XPG and subjected to adaptor ligation on both ends, followed by a second round of IP with damage specific antibodies. Purified ligation products were incubated with photolyases under blue light to repair the lesions, then PCR-amplified with index primers and sequenced by Illumina Hiseq system. SRS6200060 Hela_CPD_XR_NA_early_12_B Hela_CPD_XR_NA_early_12_B OTHER GENOMIC other Illumina HiSeq 2500